DCM
Diag Capital Management Portfolio holdings
AUM
$87.4M
1 Year Est. Return
–
AUM
$87.4M
AUM Growth
–
Holding
40
Top Buys
| 1 | +$5.66M | |
| 2 | +$5.45M | |
| 3 | +$4.95M | |
| 4 |
AbbVie
ABBV
|
+$4.65M |
| 5 |
Incyte
INCY
|
+$4.59M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 90.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
LivaNova
LIVN
$2.75B
| $1.09M | 1.25% |
+11,974
|
|
||
|
MTEM
27
DELISTED
Molecular Templates, Inc.
MTEM
| $985K | 1.13% |
+16,256
|
|
||
|
FOMX
28
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $960K | 1.1% |
+146,432
|
|
||
29
Verrica Pharmaceuticals
VRCA
$32.7M
| $937K | 1.07% |
+11,495
|
|
||
30
Neurocrine Biosciences
NBIX
$15.2B
| $876K | 1% |
+12,266
|
|
||
31
Dentsply Sirona
XRAY
$2.23B
| $757K | 0.87% |
+20,347
|
|
||
|
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
| $702K | 0.8% |
+46,485
|
|
||
|
ARYAU
33
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
| $522K | 0.6% |
+50,500
|
|
||
34
ADMA Biologics
ADMA
$3.46B
| $435K | 0.5% |
+182,100
|
|
||
35
Madrigal Pharmaceuticals
MDGL
$11.1B
| $326K | 0.37% |
+2,890
|
|
||
36
Arvinas
ARVN
$753M
| $311K | 0.36% |
+24,210
|
|
||
|
NEOS
37
DELISTED
Neos Therapeutics, Inc
NEOS
| $278K | 0.32% |
+168,642
|
|
||
38
AnaptysBio
ANAB
$1.1B
| $95K | 0.11% |
+1,493
|
|